Harvard Bioscience (HBIO) Misses Q3 EPS by 3c

November 7, 2023 7:21 AM EST

Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of $0.01, $0.03 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $25.4 million versus the consensus estimate of $28.02 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings